No evidence that protein truncating variants in <i>BRIP1</i> are associated with breast cancer risk: implications for gene panel testingDouglas F. Easton, Montserrat García‐Closas, Brennan Decker et al.|Journal of Medical Genetics|2016Cited by 104
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort StudyMd. Ismail Hosen, Florence Le Calvez‐Kelm, Paul Brennan et al.|EBioMedicine|2020Cited by 84
Hepatitis B virus preS2Δ38–55 variants: A newly identified risk factor for hepatocellular carcinomaDamien Cohen, Isabelle Chemin, A. Dubois et al.|JHEP Reports|2020Cited by 28